

Kala Pharmaceuticals develops novel treatments for diseases that affect mucosal tissues. Among its major competitors, Kala Pharmaceuticals is ranked in 2nd place for NPS while Biogen is 1st, and Athersys is 3rd.Their current valuation is $33.14M
Kala Pharmaceuticals's Net Promoter Score (NPS) is a 0 with 0% Promoters, 100% Passives, and 0% Detractors. Net Promoter Score tracks whether Kala Pharmaceuticals's customers would recommend using the product based on a scale of -100 to 100.
| 0% | Promoters |
|---|---|
| 100% | Passives |
| 0% | Detractors |
| Summary | Date | Score |
|---|---|---|
Mar 2021 0 | Mar 2021 | 0 |
Kala Pharmaceuticals is ranked second for NPS among its competitors. Biogen and MyoKardia come in first and third, with Reata Pharmaceuticals coming in at #4. Among those competitors, it is the lowest valued company behind Biogen.
![]() Kala Pharmaceuticals | ![]() Biogen | ![]() MyoKardia | ![]() Reata Pharmaceuticals | |
| Global Ranking | #- | #388 | #- | #- |
| NPS | 0 | 21 | - | - |
| Social Sentiment Calculated by analyzing social media and other online mentions | - | Neutral | Neutral | - |
| Valuation Updated every 24 hours for public companies | $33.14M | $42.46B | $11.99B | $2.95B |
Net Promoter Score (NPS) is a management tool that can be used to gauge the satisfaction of a firm's customer relationships. NPS has been widely adopted as a key metric often linked to the revenue potential of a company’s product or service. The metric is based on customer responses to the question: "On a scale of 0 to 10, how likely are you to recommend the product to a friend?"
Those who respond with a score of 9 to 10 are known as Promoters, and are widely associated with behaviors that create value, including actively encouraging others to use the product or service. Those who respond with a score of 7 or 8 are categorized as Passives, and they are believed to be less likely to exhibit the value-creation traits of Promoters having a largely neutral effect on other consumers. Detractors are those who fall in the score range of 0 to 6 and represent dissatisfied customers of the product sometimes actively recommending against using the product.
Compared to its competitors, Kala Pharmaceuticals's NPS is rated right above MyoKardia, and is preceded by Biogen.
| COMPANY | NPS Score | |
|---|---|---|
![]() | Biogen | 21 |
![]() | Kala Pharmaceuticals | 0 |
![]() | MyoKardia | N/A |
![]() | Reata Pharmaceuticals | N/A |
Customer Loyalty is a strong indicator of whether or not a customer will choose a brand repeatedly over a competitor that offers similar products/services.
100% of Kala Pharmaceuticals users/customers answered "Yes" when asked: "Would you consider yourself a loyal user/customer?"
Sign Up to see the full customer demographics data and the people that answered "Yes" when asked "Would you consider yourself a loyal user/customer?"
Compared to its competitors, Kala Pharmaceuticals's Customer Loyalty score is rated right above MyoKardia.
| COMPANY | Customer Loyalty Score | |
|---|---|---|
![]() | Kala Pharmaceuticals | 100% |
![]() | MyoKardia | 100% |
![]() | Biogen | 75% |
![]() | Reata Pharmaceuticals | N/A |
Kala Pharmaceuticals has an overall Product Quality score of 4 out of 5 stars rated by its users and customers.
Sign Up to unlock Kala Pharmaceuticals' overall Product Quality score rated by its users and customers.
Kala Pharmaceuticals’s product quality score is a 4 out of 5 as rated by its users and customers.
Compared to its competitors, Kala Pharmaceuticals's Product Quality score is rated right above MyoKardia, and is preceded by Biogen.
| COMPANY | Product Quality Score | |
|---|---|---|
![]() | Biogen | 4/5 |
![]() | Kala Pharmaceuticals | 4/5 |
![]() | MyoKardia | 4/5 |
![]() | Reata Pharmaceuticals | N/A |
Kala Pharmaceuticals has a value for money and ROI score of 4 out of 5 stars rated by its users and customers.
Sign Up to unlock Kala Pharmaceuticals' overall ROI score rated by its users and customers.
Compared to its competitors, Kala Pharmaceuticals's ROI score is rated right above MyoKardia.
| COMPANY | Pricing Score | |
|---|---|---|
![]() | Kala Pharmaceuticals | 4/5 |
![]() | MyoKardia | 4/5 |
![]() | Biogen | 3.8/5 |
![]() | Reata Pharmaceuticals | N/A |
Kala Pharmaceuticals has an overall Customer Service score of 4 out of 5 stars rated by its users and customers.
Sign Up to unlock Kala Pharmaceuticals' overall Customer Service score rated by its users and customers.
100 Beaver St., Suite 201, Waltham, MA
http://www.kalarx.com
1(781) 996-5252
Compared to its competitors, Kala Pharmaceuticals's Customer Service score is rated right above MyoKardia.
| COMPANY | Customer Service Score | |
|---|---|---|
![]() | Kala Pharmaceuticals | 4/5 |
![]() | MyoKardia | 4/5 |
![]() | Biogen | 3.8/5 |
![]() | Reata Pharmaceuticals | N/A |
Kala Pharmaceuticals scored a 0 for Net Promoter Score and a -34 for Employee Net Promoter Score. NPS gauges how likely a customer of Kala Pharmaceuticals would recommend the brand to a friend. ENPS measures how likely Kala Pharmaceuticals employees would recommend working at Kala Pharmaceuticals to a friend.
| 0% | Promoters |
|---|---|
| 100% | Passive |
| 0% | Detractors |
| 33% | Promoters |
|---|---|
| 0% | Passive |
| 67% | Detractors |